Related Experiment Video
Updated: Jan 11, 2026

Detection of Anti-MDA5 Autoantibodies Using HeLa Cells and Immunocytochemistry with Light Microscopy
Published on: October 31, 2025
Anti-Signal Recognition Particle Antibody-Positive Immune-Mediated Necrotizing Myopathy Diagnosed by Re-Evaluation
Kentaro Yoshida1, Tadashi Adachi2, Shigeaki Suzuki3
1Division of Neurology, Department of Brain and Neuroscience, Tottori University, Yonago, Japan.
Abstract:
Immune-mediated necrotizing myopathy (IMNM) is a frequent subtype of idiopathic inflammatory myopathies. Distinguishing juvenile-onset IMNM from muscular dystrophy is often difficult, particularly when the disorder takes a chronic course. We describe a 45-year-old Japanese woman with progressive generalized weakness. Her early motor milestones were normal until age 4, but by 5 years she developed Gowers' sign. At that time, she was noted to have proximal weakness, scapular winging, gait impairment, and markedly elevated serum creatine kinase (6069 IU/L). A biopsy of the left biceps brachii suggested muscular dystrophy. Her disease advanced, and she required a wheelchair during elementary school. At age 41 she was referred to the neurology department at Tottori University Hospital, and at 45 years she was re-evaluated. Examination revealed symmetric proximal weakness, atrophy, severe spinal deformity, and bilateral pes cavus. Electromyography demonstrated prominent myogenic changes, and muscle MRI disclosed profound atrophy with fatty replacement of proximal muscles. A repeat biopsy from the left tibialis anterior showed severe myofiber atrophy but no necrosis, regeneration, or inflammatory infiltration. Immunohistochemistry for dystrophy-associated proteins, MHC class I, and p62 was unremarkable. In contrast, retrospective review of the original biopsy revealed diffuse MHC class I expression and granular sarcoplasmic p62 staining, supporting a diagnosis of IMNM. Although ELISA results were negative, RNA immunoprecipitation identified anti-signal recognition particle antibodies. This patient illustrates an uncommon presentation of juvenile-onset IMNM that remained untreated for decades. The absence of characteristic histological features on biopsy performed 40 years after disease onset emphasizes the diagnostic challenges in long-standing cases. Careful reassessment of earlier tissue samples, in combination with extended antibody testing, may be essential for establishing the correct diagnosis in similar situations.
More Related Videos
08:16Utility of Dissociated Intrinsic Hand Muscle Atrophy in the Diagnosis of Amyotrophic Lateral Sclerosis
Published on: March 4, 2014
09:29Induction of Paralysis and Visual System Injury in Mice by T Cells Specific for Neuromyelitis Optica Autoantigen Aquaporin-4
Published on: August 21, 2017
Related Concept Videos
Myasthenia Gravis: Diagnostic Tests
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
Myasthenia Gravis: Overview and Treatment
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...